학술논문

MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study
Document Type
Article
Source
In The Lancet Rheumatology November 2020 2(11):e666-e676
Subject
Primary Research
Articles
Language
ISSN
2665-9913